These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24407539)

  • 1. The fourth-generation Calcium channel blocker: cilnidipine.
    Chandra KS; Ramesh G
    Indian Heart J; 2013 Dec; 65(6):691-5. PubMed ID: 24407539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice.
    Veronesi M; Cicero AF; Prandin MG; Dormi A; Cosentino E; Strocchi E; Borghi C
    Vasc Health Risk Manag; 2007; 3(6):999-1005. PubMed ID: 18200818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of antihypertensive treatment using real-world Japanese data-the retrospective study of antihypertensives for lowering blood pressure (REAL) study.
    Ohishi M; Yoshida T; Oh A; Hiroi S; Takeshima T; Otsuka Y; Iwasaki K; Shimasaki Y
    Hypertens Res; 2019 Jul; 42(7):1057-1067. PubMed ID: 30842611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacies of antihypertensive drugs.
    Aursnes I; Tvete IF; Gåsemyr J; Natvig B
    Scand Cardiovasc J; 2003 May; 37(2):72-9. PubMed ID: 12775305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease.
    Kanaoka T; Tamura K; Wakui H; Ohsawa M; Azushima K; Uneda K; Kobayashi R; Fujikawa T; Tsurumi-Ikeya Y; Maeda A; Yanagi M; Toya Y; Umemura S
    Int J Mol Sci; 2013 Aug; 14(8):16866-81. PubMed ID: 23959116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
    Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
    Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensives.
    Cranwell-Bruce LA
    Medsurg Nurs; 2008 Oct; 17(5):337-41; quiz 342. PubMed ID: 19051983
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive medications.
    Slagle MA
    South Med J; 2001 Nov; 94(11):1071-3. PubMed ID: 11780676
    [No Abstract]   [Full Text] [Related]  

  • 10. Association Between Angiotensin Receptor Blocker Therapy and Incidence of Epilepsy in Patients With Hypertension.
    Doege C; Luedde M; Kostev K
    JAMA Neurol; 2022 Dec; 79(12):1296-1302. PubMed ID: 36251288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
    Griffith TF; Chua BS; Allen AS; Klassen PS; Reddan DN; Szczech LA
    Am J Kidney Dis; 2003 Dec; 42(6):1260-9. PubMed ID: 14655199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydropyridines versus other agents in the treatment of hypertension in the elderly. Part 1: Antihypertensive therapy and left ventricular hypertrophy.
    Fagard R; Staessen J; Thijs L; Van Hoof R; Amery A
    J Hypertens Suppl; 1993 Dec; 11(6):S27-9. PubMed ID: 7909547
    [No Abstract]   [Full Text] [Related]  

  • 13. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials.
    Wang JG; Staessen JA; Li Y; Van Bortel LM; Nawrot T; Fagard R; Messerli FH; Safar M
    Stroke; 2006 Jul; 37(7):1933-40. PubMed ID: 16763185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rational approach to hypertension treatment in the older patient.
    Flack JM; Woolley A; Esunge P; Grimm RH
    Geriatrics; 1992 Nov; 47(11):24-8, 33-8. PubMed ID: 1358761
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State-of-the-art treatment of hypertension: established and new drugs.
    Burnier M; Vuignier Y; Wuerzner G
    Eur Heart J; 2014 Mar; 35(9):557-62. PubMed ID: 24216391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of antihypertensive drugs.
    Pepper GA
    J Obstet Gynecol Neonatal Nurs; 1999; 28(6):649-59. PubMed ID: 10584919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.